Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 10553

A sealed prediction that did not hold.

no effect in discovery (spearman rho -0.34, p 0.373). This receipt's hash covers every field on it, plus the hash of receipt 10552, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 10553
    26 Oct 2026, 06:00 UTC

    GSDMA

    dopamine neurons, braak

    predictionGSDMA in dopamine neurons tracks Braak Lewy-body stage

    registered2ddc0a816b3b27e2

    discovery-0.34 p=0.373 n=9

    replication-0.09 p=0.821 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho -0.34, p 0.373)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    ed9918dd7ab090275038968f…
    follows 3d87eb2b84fb…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 10553: GSDMA in dopamine neurons, braak

power
full sample -0.28 (p 0.261, n 18), 95% CI -0.66 to +0.22. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.23 (p 0.360, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.27 (p 0.273, n 18). could be the mix.
skeptic
leave-one-out range -0.41 to -0.18, sign flips 0; without severely affected donors -0.28 (p 0.261, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for GSDMA in dopamine neurons.

case closed: nothing better to follow up.